TOPLINE: Pediatric patients receiving a combination of rituximab and cyclophosphamide therapy for rheumatic disease showed clinical improvement with a low risk for adverse effects. METHODOLOGY: While […]

TOPLINE: Liver-related adverse drug reactions were nearly three times more common than kidney-related adverse drug reactions in patients with rheumatoid arthritis (RA) using methotrexate; however, fatal […]

TOPLINE:  Discontinuing concomitant methotrexate (MTX) was noninferior to continuing it for maintenance of low disease activity (LDA) in patients with rheumatoid arthritis (RA) who had already […]

TOPLINE: Yoga and strengthening exercises both reduced knee pain in patients with knee osteoarthritis (OA) over 12 weeks, with no significant difference between them. Over 24 […]

TOPLINE: Discontinuing prophylactic trimethoprim-sulfamethoxazole (TMP-SMX) while patients with autoimmune or inflammatory disease (AIID) were receiving > 12.5 mg/d of prednisone-equivalent glucocorticoids significantly increased the risk for […]

TOPLINE: High serum type I interferon (IFN) scores, measured through six chemokines, correlated with poorer lung function and health-related quality of life in patients with diffuse […]

TOPLINE: Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease-modifying antirheumatic […]